Related Experiment Videos
Gamma/delta T lymphocytes in Mycobacterium tuberculosis infection
Z Balikó1, L Szereday, J Szekeres-Bartho
1Department of Pulmonology, County Hospital, Pécs, Hungary.
Thorax
|April 1, 1997
Summary
Tuberculin-negative tuberculosis patients show higher gamma/delta T lymphocyte percentages than tuberculin-positive patients or controls. This may indicate a shift towards a Th2 immune response in anergic individuals.
Area of Science:
- Immunology
- Tuberculosis Research
- Flow Cytometry
Background:
- Limited and conflicting data exist on gamma/delta T lymphocyte percentages in Mycobacterium tuberculosis infection.
- Understanding these immune cell populations is crucial for diagnosing and managing tuberculosis.
Purpose of the Study:
- To compare gamma/delta T lymphocyte percentages in the peripheral blood of patients with Mycobacterium tuberculosis infection (tuberculin-positive and tuberculin-negative) and healthy controls.
- To investigate the potential role of gamma/delta T cells in tuberculosis immunopathology.
Main Methods:
- Peripheral blood lymphocytes were isolated from 36 tuberculosis patients and 11 healthy controls.
- Cells were stained with anti-gamma/delta monoclonal antibody and analyzed via microscopy.
- The percentage of gamma/delta T lymphocytes was quantified by counting 300 lymphocytes per sample.
Main Results:
- No significant difference in gamma/delta T lymphocyte percentage was observed between tuberculosis patients and healthy controls.
- Tuberculin-negative tuberculosis patients exhibited a higher percentage of gamma/delta T lymphocytes compared to tuberculin-positive patients.
- A higher proportion of gamma/delta T lymphocytes was found in tuberculin-anergic patients than in tuberculin-positive patients or controls.
Conclusions:
- Elevated gamma/delta T cell counts are associated with tuberculin negativity in tuberculosis patients.
- High gamma/delta T cell counts in anergic patients may suggest a Th2-biased immune response.
- This Th2 shift could involve increased antibody production and diminished cell-mediated immunity in certain tuberculosis cases.